Liquidia (LQDA) Net Margin Growth (1y) (2021 - 2026)
Liquidia (LQDA) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Liquidia | 6.40 Bn | 6.12 Bn | 160.92 Mn | 51,402.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51,402.00 |
| Mar 31, 2026 | 126,951.00 |
| Dec 31, 2025 | 133,601.00 |
| Sep 30, 2025 | 141,499.00 |
| Jun 30, 2025 | 136,917.00 |
| Mar 31, 2025 | 287,396.00 |
| Dec 31, 2024 | -71,437.00 |
| Sep 30, 2024 | -84,302.00 |
| Jun 30, 2024 | -144,245.00 |
| Mar 31, 2024 | -341,364.00 |
| Dec 31, 2023 | -51,012.00 |
| Sep 30, 2023 | -23,566.00 |
| Jun 30, 2023 | -74,171.00 |
| Mar 31, 2023 | -23,688.00 |
| Dec 31, 2022 | 26,115.00 |
| Sep 30, 2022 | -17,996.00 |
| Jun 30, 2022 | -13,044.00 |
| Mar 31, 2022 | 7,359.00 |
| Dec 31, 2021 | 181,307.00 |